Evidence map›Paper›PMID 37192898›Full record

ReviewInternational journal of nanomedicine2023

Metal-Based Nanoparticles: A Prospective Strategy for

Xiaojing Yin, Yongkang Lai, Yiqi Du, Tinglin Zhang, Jie Gao, Zhaoshen Li

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of nanomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. RSC advances · 2025
    Review
  10. Frontiers in microbiology · 2025
    Review
  11. Review
  12. Implications of silver nanoparticles forFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaojing Yin *Department of Gastroenterology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, 200433, People's Republic of China.
Yongkang Lai *Department of Gastroenterology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, 200433, People's Republic of China.
Yiqi Du *Department of Gastroenterology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, 200433, People's Republic of China.ORCID 0000-0002-4261-6888
Tinglin Zhang *Changhai Clinical Research Unit, Shanghai Changhai Hospital, Naval Medical University, Shanghai, 200433, People's Republic of China.
Jie GaoChanghai Clinical Research Unit, Shanghai Changhai Hospital, Naval Medical University, Shanghai, 200433, People's Republic of China.
Zhaoshen LiDepartment of Gastroenterology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, 200433, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Helicobacter InfectionsHelicobacter pyloriNanoparticlesAnti-Bacterial AgentsBismuthDrug Therapy, CombinationHumansProton Pump InhibitorsAnti-Bacterial AgentsBismuthProton Pump Inhibitorsantibiotic-freeantimicrobial applicationsantimicrobial mechanismsH. pylorimetal based nanoparticles

Identifiers

PMID37192898
PMCPMC10182771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.